13-25468959-T-G

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2

The NM_016529.6(ATP8A2):​c.77-18T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00281 in 1,613,054 control chromosomes in the GnomAD database, including 9 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.0016 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0029 ( 9 hom. )

Consequence

ATP8A2
NM_016529.6 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.891

Publications

0 publications found
Variant links:
Genes affected
ATP8A2 (HGNC:13533): (ATPase phospholipid transporting 8A2) The protein encoded by this gene is a member of the P4 ATPase family of proteins, which are thought to be involved in a process called lipid flipping, whereby phospholipids are translocated inwards from the exoplasmic leaflet to the cytosolic leaflet of the cell membrane, which aids in generating and maintaining asymmetry in membrane lipids. This protein is predicted to contain an E1 E2 ATPase, a haloacid dehalogenase-like hydrolase (HAD) domain, and multiple transmembrane domains. Associations between this protein and cell cycle control protein 50A are important for translocation of phosphatidylserine across membranes. Mutations in this gene have been associated with a syndrome (CAMRQ4) characterized by cerebellar ataxia and cognitive disabilities. In addition, a translocation breakpoint within this gene was observed in an individual with neurological dysfunction. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jul 2017]
ATP8A2 Gene-Disease associations (from GenCC):
  • cerebellar ataxia, intellectual disability, and dysequilibrium
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • cerebellar ataxia, intellectual disability, and dysequilibrium syndrome 4
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.62).
BP6
Variant 13-25468959-T-G is Benign according to our data. Variant chr13-25468959-T-G is described in ClinVar as Benign. ClinVar VariationId is 1599231.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00163 (249/152296) while in subpopulation NFE AF = 0.00238 (162/68016). AF 95% confidence interval is 0.00208. There are 0 homozygotes in GnomAd4. There are 130 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 9 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_016529.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATP8A2
NM_016529.6
MANE Select
c.77-18T>G
intron
N/ANP_057613.4
ATP8A2
NM_001411005.1
c.77-18T>G
intron
N/ANP_001397934.1A0A804HKW9
ATP8A2
NM_001313741.1
c.-44-18T>G
intron
N/ANP_001300670.1Q9NTI2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATP8A2
ENST00000381655.7
TSL:1 MANE Select
c.77-18T>G
intron
N/AENSP00000371070.2Q9NTI2-4
ATP8A2
ENST00000281620.11
TSL:1
n.77-18T>G
intron
N/AENSP00000281620.7F8W9B3
ATP8A2
ENST00000684424.1
c.-62T>G
5_prime_UTR
Exon 1 of 36ENSP00000507489.1Q9NTI2-1

Frequencies

GnomAD3 genomes
AF:
0.00164
AC:
249
AN:
152180
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000555
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000589
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00499
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00238
Gnomad OTH
AF:
0.000956
GnomAD2 exomes
AF:
0.00189
AC:
469
AN:
248168
AF XY:
0.00206
show subpopulations
Gnomad AFR exome
AF:
0.000907
Gnomad AMR exome
AF:
0.000233
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00515
Gnomad NFE exome
AF:
0.00287
Gnomad OTH exome
AF:
0.00216
GnomAD4 exome
AF:
0.00293
AC:
4286
AN:
1460758
Hom.:
9
Cov.:
31
AF XY:
0.00280
AC XY:
2032
AN XY:
726640
show subpopulations
African (AFR)
AF:
0.000299
AC:
10
AN:
33428
American (AMR)
AF:
0.000224
AC:
10
AN:
44680
Ashkenazi Jewish (ASJ)
AF:
0.0000766
AC:
2
AN:
26096
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39630
South Asian (SAS)
AF:
0.0000464
AC:
4
AN:
86196
European-Finnish (FIN)
AF:
0.00543
AC:
290
AN:
53380
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5758
European-Non Finnish (NFE)
AF:
0.00349
AC:
3875
AN:
1111276
Other (OTH)
AF:
0.00158
AC:
95
AN:
60314
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.464
Heterozygous variant carriers
0
200
399
599
798
998
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
160
320
480
640
800
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00163
AC:
249
AN:
152296
Hom.:
0
Cov.:
33
AF XY:
0.00175
AC XY:
130
AN XY:
74468
show subpopulations
African (AFR)
AF:
0.000553
AC:
23
AN:
41578
American (AMR)
AF:
0.000588
AC:
9
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5164
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
0.00499
AC:
53
AN:
10614
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00238
AC:
162
AN:
68016
Other (OTH)
AF:
0.000946
AC:
2
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.510
Heterozygous variant carriers
0
13
25
38
50
63
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000863
Hom.:
0
Bravo
AF:
0.00132

ClinVar

ClinVar submissions as Germline
Significance:Benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.62
CADD
Benign
9.4
DANN
Benign
0.46
PhyloP100
-0.89
PromoterAI
-0.026
Neutral
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs199807614; hg19: chr13-26043097; API